Bacthera receives manufacturing licenses in Switzerland and Denmark
Bacthera, Chr. Hansen’s joint venture with Lonza, reaches a key milestone and is ready to start supplying Live Biotherapeutic Products
Chr. Hansen launches global science-based online platform on probiotics
With more than 55 million hits on “probiotics” online, it can be hard to find science-based information from trustworthy sources. As an industry leader, Chr. Hansen is therefore launching The Probiotics Institute™ – a new platform providing educational and scientific content on probiotics and the human microbiome.
Chr. Hansen and Nestlé settle court case about Human Milk Oligosaccharides patent infringements
In October 2020, Chr. Hansen acquired Jennewein Biotechnologie GmbH including a strong patent portfolio relating to the production of Human Milk Oligosaccharides (HMOs) and several litigations related hereto.
Before the acquisition in January 2020, Jennewein requested an injunction at the courts of Mannheim, Germany, against Nestlé’s sale of its infant formula products containing HMOs from a t
Chr. Hansen launches VEGA™ Culture Kit specifically developed for fermented plant bases
The VEGA™ Culture Kit is comprised of customizable starter cultures, probiotics and bioprotective strains, specifically developed for fermented plant-bases.
Chr. Hansen launches the next generation of FreshQ® food cultures for fermentation- enabled bioprotection of dairy products
FreshQ® cultures, specifically developed to unlock the benefits of bioprotection for producers who may experience challenged cold chains, long fermentation, and in-process holding times.
New study: Probiotics may offer immune balancing benefits while improving sleep and stress of rotation shift workers
Irregular sleep patterns are associated with immune health and may underpin a range of health issues in rotation shift workers. By supporting the intestinal microbiota, probiotic supplements may lessen the negative impact of interrupted sleep on the immune system, new study suggests.
Chr. Hansen, in collaboration with Griffith University, recently completed a study* on the impact of stress, sle
Chr. Hansen continues strong momentum: 10% organic growth in Q2
Good results across business areas and regions secure upwards narrowing of full-year guidance. Extraordinary dividend announced for pay-out in May.
Continued strong organic growth momentum leads to upwards narrowing of full-year organic growth guidance.
Q2 2020/21 organic sales growth was 10%, equally split between volume/mix and price, and driven by Health & Nutrition which deliver
Chr. Hansen Natural Colors transaction closed
Divestment of Natural Colors to EQT closed as of March 31, 2021
Chr. Hansen reports strong organic growth of 10% for Q1
Off to a positive start to 2020/21 with good commercial traction and integration of acquisitions on track
Q1 2020/21 organic sales growth was 10%, equally split between volume/mix and price, and driven by Health & Nutrition, which delivered 15% growth, while Food Cultures & Enzymes delivered 8% growth
Underlying EBIT margin b.s.i. (see reconciliation on p. 20) of 28.5%, incl. 1%-po
Chr. Hansen launches probiotic lozenges for dental health
Chr. Hansen introduces probiotic lozenges that dissolve in the mouth. It is a convenient solution with scientifically documented ingredients for the maintenance of dental health.
Chr. Hansen extends its FreshQ® bioprotection solution into the fermented plant-based segment
The new FreshQ® DA culture combines Chr. Hansen’s 145 years of expertise in food microbiology with a focus on fermentation solutions for plant-based products to help keep them naturally safe and fresh for longer.
Chr. Hansen launches next-generation Premium cultures for fresh dairy producers committed to excellence
YoFlex® Premium and nu-trish® Premium are The Perfect Partner™ for creating high-textured yogurt with fewer additives and a healthier profile
Show more
Loading...
